Cancer52 is working with Genetic Alliance on its patient charter, My Cancer My DNA. Genetic Alliance today (8 March) has launched its new...

Cancer52 has become a partner in Genetic Alliance's 'My Cancer, My DNA' project, together with Cancer Research UK, Bloodwise and Breast...

A new study, published today (26 February) looks at the challenges of timely diagnosis for people with rarer cancers. Authored by Silvia...

Cancer52 has published a position paper 'Cancer 52 Position Paper on Access to Medicines and Treatments' which gives a clear view on the...

Available for the first time at Britain Against Cancer on 8 December are two new briefings from Cancer52: "Living with a rare or less...

Our thanks to Stopgap who have donated £400 to Cancer52. Stopgap is a small (50 people) owner managed business which finds marketing...

Chair Jonathan Pearce is interviewed on BBC Radio 4's Inside Health Programme on the Cancer Drug Fund and the extra challenges faced by...

Jonathan Pearce, Chair of Cancer52, said: "Cancer52 calls on NHS England to learn from The National Audit Office’s report[1] and ensure...

Cancer52 comment on Cancer Drug Fund announcement of 4 September 2015.

The Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020 was published in July 2015. Cancer52, a coalition of more...